Gut Microbiota and Its Infl uence on Developing Irritable Bowel Syndrome: A Review

Read full text Summarise with VIRAT
Authors: Riya Khurana, Gurseen Rakhra
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Irritable Bowel Syndrome (IBS) has a global prevalence of 11%, and it is amongst the most frequent gastrointestinal diseases. It is characterised by an impaired bowel function displaying symptoms such as changed stool habits accompanied by abdominal pain and discomfort. A major risk factor attributed to IBS is a dysbiotic gut that leads to infl ammation and abnormal intestinal immune activity. Diet is known to alter gut microbiota. Therefore, a diet rich in Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols (FODMAP) is considered to be a risk factor since it causes visceral hypersensitivity, impaired gut motility and dysbiosis, promoting faster fermentation by gut microbiota and causing gas. Aim: This review highlights the association of gut microbiota with IBS and an increase in studies of genome sequencing that help in the early identifi cation of chronic disease development. Materials and Methods: We searched PubMed, Medline, and Google Scholar for articles published in English between 2000 and December 2021 using the keywords “gut microbiota,” “microbiota,” “pathogenesis,” “infl ammatory bowel diseases,” and “irritable bowel syndrome”. An average of 200 research publications was examined; those that did not include gut-related variables or the risk of acquiring noncommunicable diseases were excluded. Results: Studies have shown that patients suffering from IBS have a distinct gut microbiota, and certain bacteria are linked to the intestinal symptoms. There is a reduced microbial diversity in IBS patients. There was an abundance of Firmicutes and a decreased number of Bacteroidetes. There is a direct relationship between IBS and the number of harmful bacteria like E. coli, Clostridium and Ruminococcus. Faecal bacterium prausnitzii was lower in IBS patients, making it a “good gut signature”. Contrary to popular belief, Lactobacillus and Bifi dobacterium, which are used as probiotics, were increased in patients with IBS. Conclusion: Gut microbiota is now being studied immensely and is regarded as the “second brain”. Recent microbiome gene sequencing has displayed a great number of links between gut microbiota composition and the development of gastrointestinal disorders such as IBS.

Fields of Study & Subjects

Gut microbiota and health Gastrointestinal motility and disorders Inflammatory Bowel Disease

Publication details

Journal / source
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Publication date
1 March 2026
Language
EN